brainimmunex

We pursue
Shift in Perspective

We pursue
Continuous communication and discussion

We pursue
Humility and Respect

About Us

Unveiling Fundamental Solutions for Age-Related Brain Diseases through Brain immunity Better medicine for humanity

Company

We are the pioneering new drug development company, specializing in brain immunity. Our primary focus is on developing treatments for intractable brain diseases associated with aging, utilizing an innovative platform technology that rejuvenates brain immunity-related cells, microglia.
Mission

Brainimmunex's mission is to develop brain immunity-rejuvenating therapeutics for age-related CNS diseases. To achieve this goal, we employ an interdisciplinary approach to address challenging brain diseases, including Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Parkinson’s diseases, and Glioblastoma multiforme.
Strategy

1. Core Platform strategy

- Dedication to continuous efforts for innovation

2. Business scale up strategy

- Pipeline expansion

3. Sustainable business model

- Building a diverse product line, step by step

"BrainImmunex's research approach and innovative resources in rejuvenation of microglia signify a commitment to developing therapeutics that are not only differentiating but also more effective than current options for brain diseases."